Relationship between amount of pleural effusion and etiology Source: Eur Respir J 2006; 28: Suppl. 50, 579s Year: 2006
Clinical parameters influencing fluid amount change and residual thickening in tuberculous pleurisy Source: Eur Respir J 2004; 24: Suppl. 48, 423s Year: 2004
Therapeutic outcome and prognostic factors in patients with pleural mesothelioma Source: Eur Respir J 2005; 26: Suppl. 49, 73s Year: 2005
Clinical and radiological evaluation of pleural effusions at different volume ranges Source: Eur Respir J 2004; 24: Suppl. 48, 538s Year: 2004
The value of biochemical parameters of the pleural aspirate in predicting success of chemical pleurodesis in malignant pleural effusion Source: Annual Congress 2010 - Oncological problems, surgical risk and complications Year: 2010
Is the size of pleural effusion important in the study of patients whose first tumor manifestation is a pleural effusion? Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017
Is pleural VEGF a useful parameter? Source: Annual Congress 2007 - Pleural malignancy Year: 2007
Potential role of total antioxidant status ratio in differential diagnosis of pleural effusion Source: Annual Congress 2013 –Interventional pulmonology and pleural diseases Year: 2013
Clinical and epidemiological features of tuberculous pleural effusion Source: Eur Respir J 2005; 26: Suppl. 49, 657s Year: 2005
The diagnostic role of pleural fluid and serum Pentraxin-3 levels in the determination of the etiology of pleural effusion Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases Year: 2017
Use of cytokines in the diagnosis and outcome correlation of tuberculous pleural effusion Source: Eur Respir J 2002; 20: Suppl. 38, 210s Year: 2002
Understanding how variation in clinical practice affects length of stay for patients with malignant pleural effusion. Source: International Congress 2019 – Pleural disease: applying the evidence Year: 2019
Reumathoid factor: diagnostic utility in pleural fluid Source: Eur Respir J 2003; 22: Suppl. 45, 191s Year: 2003
Diagnostic utility of biochemical parameters in patients with pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 386s Year: 2001
The role of CTPA in investigating a patient with a pleural effusion of unknown etiology Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status Year: 2021
Investigating unilateral pleural effusions: the role of cytology. Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018
Thoracoscopic evaluation of the effect of tumour burden on the outcome of pleurodesis in malignant pleural effusion Source: Virtual Congress 2021 – Pleural disease and bronchoscopic lung volume reduction Year: 2021
Does the age affect the diagnostic yield of different biomarkers in differentiation between tuberculous and non-tuberculous pleural effusions? Source: International Congress 2017 – Human susceptibility to tuberculosis Year: 2017
Assessment of accuracy of clinical techniques for detection of pleural effusions: comparison with radiological methods Source: Eur Respir J 2002; 20: Suppl. 38, 474s Year: 2002
Utility of pleural fluid for predictive marker testing in malignant pleural effusion Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020